NCT04526366View on ClinicalTrials.gov

Apnoea-Hypopnoea-Indices Determined Via Continuous Positive Airway Pressure vs Those Determined by Polysomnography

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Sleep Apnea Syndromes
Interventions
DEVICE

Continuous Positive Airway Pressure

Continuous Positive Airway Pressure device deployed for at least one night synchronously with polysomnography.

DEVICE

Polysomnography

Polysomnography deployed for at least one night synchronously with Continuous Positive Airway Pressure.

Trial Locations (1)

34925

University Hospitals of Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04526366 - Apnoea-Hypopnoea-Indices Determined Via Continuous Positive Airway Pressure vs Those Determined by Polysomnography | Biotech Hunter | Biotech Hunter